• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO MEDICAL CORPORATION R2P MISAGO RX SELF-EXAPNDING PERIPHERAL STENT; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO MEDICAL CORPORATION R2P MISAGO RX SELF-EXAPNDING PERIPHERAL STENT; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number N/A
Device Problem Stretched (1601)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/01/2024
Event Type  Injury  
Manufacturer Narrative
A1: patient identifier: requested, not available.A2: age or date of birth: requested, not available.A3a: sex: requested, not available.A3b: gender: n/a.A4: weight: requested, not available.A5: ethnicity: requested, not available.A6: race: requested, not available.D4: lot #: requested, unknown.D4: expiration date: unknown, as the involved product lot # was unknown.D4: udi: n/a as this product code is not exported to the us market.D6a: implanted date: device was not implanted.D6b: explanted date: device was not explanted.H4: device manufacture date: unknown, as the involved product lot # was unknown.The actual device was not returned; therefore, an evaluation of the actual device was unable to be conducted.The involved production lot was unknown, regarding the involved product code, review of the manufacturing record and the shipping inspection record of the production lots for the past three years (equivalent to the expiration period) from the date of occurrence was performed, and no anomaly was found.Since the involved production lot was unknown, a search of the complaint file regarding the involved product code for the past three years (equivalent to the expiration period) was performed, and no other similar report from other facilities was found.This product has a structure in which the stent self-expands by turning the thumbwheel (winding up the release wire connected to the sliding part) and pulling the sliding part toward the proximal side.Regarding the stent elongation, the following simulation tests were conducted in the past.In the simulated lower limb blood vessel model, a contralateral approach was taken with factory-retained destination 6fr 45cm, and the distal end of destination was positioned at the iliac.Then, a factory retained misago was inserted to the sfa along our guidewire.Pulling force was applied while the stent was in the middle of being released.As a result, the stent was elongated with wider spaces between the struts.Cause of occurrence/conclusion; based on our past knowledge, it was thought possible that tensile force toward the proximal side was applied to the actual sample while the stent was being released, which resulted in the elongation of stent; however, the cause of occurrence could not be clarified.Relevant instructions for use (ifu) reference: to maintain the position of the delivery catheter while rotating the thumbwheel, grip the delivery catheter by hand at the operator side (proximal) of the intermediate shaft and do not move the delivery catheter at the operator side of the intermediate shaft.·do not pull the delivery system tight during stent deployment.(the stent can become elongated during deployment.Terumo medical products (tmp) (importer) registration no.(b)(4) is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.(b)(4).
 
Event Description
The user facility reported that the involved misago 8-100 device was placed after a percutaneous old balloon angioplasty (poba), and after that, the stent was found elongated, so post dilation with senri 7-4 was added to finish the procedure.The stent was pulled with tension during alignment before being placed.Though no health hazard to the patient, the stent was elongated and additional treatment with competitor's device was required.The procedure outcome was completed successfully.The event occurred intra-operative.The final patient impact was not harmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
R2P MISAGO RX SELF-EXAPNDING PERIPHERAL STENT
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
TERUMO MEDICAL CORPORATION
950 elkton blvd.
elkton MD 21921
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
gina digioia
265 davidson ave
suite 320
somerset, NJ 08873
4103927218
MDR Report Key19009008
MDR Text Key338981219
Report Number9681834-2024-00037
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P140002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/30/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberSX-LMA08X0RN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/01/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-